Metformin reduces serum müllerian-inhibiting substance levels in women with polycystic ovary syndrome after protracted treatment

Metformin treatment of PCOS leads to rapid suppression of A and improved menstrual frequency. Suppression of MIS is a delayed response that may be secondary to the development of a cohort of follicles that underwent initial recruitment in an environment of reduced insulin stimulation.